FPX Nickel Announces Results of 2018 Annual General and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
506
FPX Nickel Announces Results of 2018 Annual General and Special Meeting

VANCOUVER, British Columbia, May 23, 2018 (GLOBE NEWSWIRE) -- FPX Nickel Corp. (TSX.V:FPX) (“ FPX Nickel ” or the “ Company ”) is pleased to announce the results of its 2018 Annual General and Special Meeting held earlier today. 

At the meeting, the shareholders voted to set the number of Board members at seven and elected Peter M.D. Bradshaw, James S. Gilbert, Peter J. Marshall, John A. McDonald, William H. Myckatyn, Robert B. Pease and Martin E. Turenne as directors of the Company to hold office for the ensuing year.  The shareholders also voted in favour of the appointment of DeVisser Gray LLP as the auditor of the Company for the ensuing year and approved the Company’s 10% Rolling Stock Option Plan.

The Company notes that Mr. John Gammon, who had served with distinction on the Board since 2008, did not stand for re-election at the meeting. 

“On behalf of the Company’s Board, our shareholders and myself, I would like to extend my very great appreciation to John for his many years of dedicated service,” said Mr. Bradshaw, Chairman of the Board.  “John has been instrumental in the evolution of the Company over the years and he will be missed.  We wish him very well indeed in his future endeavours.”

About FPX Nickel Corp.

FPX Nickel Corp. is focused on the exploration and development of the Decar Nickel-Iron Alloy Project, located in central British Columbia, and other occurrences of the same unique style of naturally occurring nickel-iron alloy mineralization known as awaruite. For more information, please view the Company’s website at www.fpxnickel.com or contact Martin Turenne, President and CEO, at (604) 681-8600.

On behalf of FPX Nickel Corp. "Martin Turenne" Martin Turenne, President, CEO and Director

Forward-Looking Statements Certain of the statements made and information contained herein is considered “forward-looking information” within the meaning of applicable Canadian securities laws. These statements address future events and conditions and so involve inherent risks and uncertainties, as disclosed in the Company's periodic filings with Canadian securities regulators. Actual results could differ from those currently projected. The Company does not assume the obligation to update any forward-looking statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Capacitor Bank Market Growth Predictions Through 2033

Updated Category News Views 216

Capacitor Bank Market Set for Substantial Growth Recently, a comprehensive report highlighted the significant potential of the global capacitor bank market, forecasting a growth trajectory that sees its value increasing from $4.3 billion in 2023 to an impressive $6.8 billion by 2033. This translates to a compound annual growth rate (CAGR) of 4.8% during the period from...

Continue Reading
Understanding Rental Affordability Trends Across Major Markets

Updated Category News Views 291

Rental Affordability Trends in August 2024 As summer draws to a close, many renters are taking a close look at the housing market to gauge current affordability rates. A recent report highlights encouraging data, showing that rental affordability has generally improved in various major U.S. regions. This article outlines the key takeaways regarding rental affordability...

Continue Reading
Stallergenes Greer’s Palforzia® Gains European Approval for Toddlers

Updated Category News Views 134

Palforzia® Receives European Commission Approval for Toddlers Stallergenes Greer, a leader in allergen immunotherapy, has exciting news: the European Commission has officially approved the use of Palforzia® for toddlers aged 1 to 3 years with confirmed peanut allergies. This significant step enhances the treatment landscape for peanut allergies and opens new doors for...

Continue Reading
ProVen Growth and Income VCT's Latest Interim Management Insights

Updated Category News Views 174

ProVen Growth and Income VCT plc Overview ProVen Growth and Income VCT plc, known for its investment strategies and market presence, has released its Interim Management Statement for the recent quarter. This report highlights significant financial data and key developments that occurred from March to May 2025, offering shareholders insights into the company’s...

Continue Reading
Treefera Recognized as 2025 Gartner® Cool Vendor in Tech

Updated Category News Views 179

Treefera Honored as a 2025 Gartner® Cool Vendor Treefera has recently celebrated a significant milestone by being named a 2025 Gartner® Cool Vendor in Sourcing and Procurement Technology. This prestigious acknowledgment underscores Treefera's innovative contributions to the supply chain sector, particularly in providing first-mile visibility which is crucial for...

Continue Reading